- Home
- LBTYK vs SRRK Comparison
LBTYK vs SRRK Comparison
Compare LBTYK & SRRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LBTYK
- SRRK
- Stock Information
- Founded
- LBTYK 2004
- SRRK 2012
- Country
- LBTYK Bermuda
- SRRK United States
- Employees
- LBTYK N/A
- SRRK N/A
- Industry
- LBTYK Cable & Other Pay Television Services
- SRRK Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- LBTYK Telecommunications
- SRRK Health Care
- Exchange
- LBTYK Nasdaq
- SRRK Nasdaq
- Market Cap
- LBTYK 3.5B
- SRRK 3.2B
- IPO Year
- LBTYK N/A
- SRRK 2018
- Fundamental
- Price
- LBTYK $10.26
- SRRK $37.44
- Analyst Decision
- LBTYK
- SRRK Strong Buy
- Analyst Count
- LBTYK 0
- SRRK 6
- Target Price
- LBTYK N/A
- SRRK $42.17
- AVG Volume (30 Days)
- LBTYK 1.1M
- SRRK 1.4M
- Earning Date
- LBTYK 01-01-0001
- SRRK 08-07-2025
- Dividend Yield
- LBTYK N/A
- SRRK N/A
- EPS Growth
- LBTYK N/A
- SRRK N/A
- EPS
- LBTYK N/A
- SRRK N/A
- Revenue
- LBTYK $4,421,800,000.00
- SRRK N/A
- Revenue This Year
- LBTYK $8.29
- SRRK N/A
- Revenue Next Year
- LBTYK $0.74
- SRRK $502.60
- P/E Ratio
- LBTYK N/A
- SRRK N/A
- Revenue Growth
- LBTYK 32.44
- SRRK N/A
- 52 Week Low
- LBTYK $9.21
- SRRK $6.76
- 52 Week High
- LBTYK $22.14
- SRRK $46.98
- Technical
- Relative Strength Index (RSI)
- LBTYK 51.59
- SRRK 59.82
- Support Level
- LBTYK $10.14
- SRRK $33.60
- Resistance Level
- LBTYK $10.37
- SRRK $38.15
- Average True Range (ATR)
- LBTYK 0.28
- SRRK 1.91
- MACD
- LBTYK 0.03
- SRRK 0.21
- Stochastic Oscillator
- LBTYK 59.55
- SRRK 89.12
About LBTYK Liberty Global Ltd. Class C
Liberty Global is a holding company with interests in several telecom companies in the UK, the Netherlands, Belgium, Switzerland, Ireland, and Slovakia. Liberty owns the main cable network in each of these geographies, and has pursued a strategy since 2016 to merge or partner with mobile-network operators to be able to offer converged services. Liberty also owns minority stakes in other media, entertainment, and cloud companies.
About SRRK Scholar Rock Holding Corporation
Scholar Rock Holding Corp is a late-stage biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for treating serious diseases in which signaling by protein growth factors plays a fundamental role. Its pipeline includes Neuromuscular and Obesity, Immuno-oncology, Fibrotic Disease, and Hematology. The group operates and manages its business as a single segment to assess performance and make operating decisions.